{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:46:39Z","timestamp":1780141599867,"version":"3.54.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.aohep.2023.101108","type":"journal-article","created":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T19:38:10Z","timestamp":1682278690000},"page":"101108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)"],"prefix":"10.1016","volume":"28","author":[{"given":"James M.","family":"Paik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E","family":"Eberly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Kabbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Harring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9313-577X","authenticated-orcid":false,"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2023.101108_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.750529","article-title":"Burnout among healthcare workers in the COVID 19 era: a review of the existing literature","volume":"9","author":"Leo","year":"2021","journal-title":"Front Public Health"},{"issue":"41","key":"10.1016\/j.aohep.2023.101108_bib0002","doi-asserted-by":"crossref","first-page":"e5048","DOI":"10.1097\/MD.0000000000005048","article-title":"Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: the quality-adjusted cost of care","volume":"95","author":"Younossi","year":"2016","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.aohep.2023.101108_bib0003","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/hep.30125","article-title":"Patient-reported outcomes and the economic effects of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: the value proposition","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101108_bib0004","unstructured":"Medicare Payment Advisory Commission. Report to the congress: reforming the delivery system. https:\/\/www.medpac.gov\/research_area\/delivery-system-reforms\/page\/43\/. Last accessed on 3\/18\/2022"},{"key":"10.1016\/j.aohep.2023.101108_bib0005","unstructured":"Centers for Medicare and Medicaid Services. (2022) Hospital-wide all-cause unplanned readmission (HWR) measure. http:\/\/www.qualitynet.org\/dcs\/ContentServer?c=Page&pagename=QnetPublic%2FPage%2FQnetTier4&cid=1228772504318. Last accessed on 3\/18\/22"},{"key":"10.1016\/j.aohep.2023.101108_bib0006","unstructured":"Centers for Medicare and Medicaid Services. (2022) Acute inpatient PPS. http:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/AcuteInpatientPPS\/index.html. Last accessed on 3\/18\/22"},{"issue":"20","key":"10.1016\/j.aohep.2023.101108_bib0007","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/CIRCULATIONAHA.114.010270","article-title":"Hospital readmissions reduction program","volume":"131","author":"McIlvennan","year":"2015","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.aohep.2023.101108_bib0008","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2215\/CJN.02600317","article-title":"National estimates of 30-day unplanned readmissions of patients on maintenance hemodialysis","volume":"12","author":"Chan","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.aohep.2023.101108_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6476","article-title":"Factors associated with unplanned 30-day readmissions after hematopoietic cell transplantation among US hospitals","volume":"2","author":"Dhakal","year":"2019","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.aohep.2023.101108_bib0010","unstructured":"Centers for Disease Control. Chronic liver disease and cirrhosis. http:\/\/www.cdc.gov\/nchs\/fastats\/liver-disease.htm. Last Accessed March 18, 2022."},{"issue":"5","key":"10.1016\/j.aohep.2023.101108_bib0011","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cgh.2016.07.020","article-title":"Direct and indirect economic burden of chronic liver disease in the United States","volume":"15","author":"Stepanova","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2023.101108_bib0012","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.14309\/ajg.0000000000001292","article-title":"Trends in the economic burden of chronic liver diseases and cirrhosis in the United States: 1996-2016","volume":"116","author":"Ma","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.aohep.2023.101108_bib0013","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.aohep.2023.101108_bib0014","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/liv.14135","article-title":"Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014","volume":"39","author":"Kim","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2023.101108_bib0015","unstructured":"Healthcare Cost and Utilization Project. Overview of the Nationwide Readmissions Database (NRD) https:\/\/www.hcup-us.ahrq.gov\/nrdoverview.jsp. December 1, 2020. Accessed March 3, 2021"},{"issue":"4","key":"10.1016\/j.aohep.2023.101108_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the burden of chronic liver disease among hospitalized US adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.aohep.2023.101108_bib0017","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2013.04.005","article-title":"Underestimation of liver-related mortality in the United States","volume":"145","author":"Asrani","year":"2013","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.aohep.2023.101108_bib0018","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep4.1419","article-title":"Mortality related to nonalcoholic fatty liver disease is increasing in the United States","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.aohep.2023.101108_bib0019","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep4.1510","article-title":"Nonalcoholic fatty liver disease and alcoholic liver disease are major drivers of liver mortality in the United States","volume":"4","author":"Paik","year":"2020","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.aohep.2023.101108_bib0020","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/MLR.0000000000000735","article-title":"Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ elixhauser comorbidity index","volume":"55","author":"Moore","year":"2017","journal-title":"Med Care"},{"issue":"11","key":"10.1016\/j.aohep.2023.101108_bib0021","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.aohep.2023.101108_bib0022","unstructured":"Elixhauser comorbidity software refined for Icd-10-Cm; https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/comorbidityicd10\/comorbidity_icd10.jsp, Accessed Oct 13, 2022"},{"key":"10.1016\/j.aohep.2023.101108_bib0023","series-title":"Department of community health sciences, in the max rady college of medicine","year":"2022"},{"key":"10.1016\/j.aohep.2023.101108_bib0024","unstructured":"Elixhauser Comorbidity Index, Department of community health sciences. http:\/\/mchp-appserv.cpe.umanitoba.ca\/viewConcept.php?conceptID=1436"},{"key":"10.1016\/j.aohep.2023.101108_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.aohep.2023.101108_bib0026","unstructured":"Consumer Price Index. Obtained from https:\/\/www.bls.gov\/cpi\/. Last accessed on 3\/18\/2022"},{"key":"10.1016\/j.aohep.2023.101108_bib0027","series-title":"Healthcare Cost and Utilization Project (HCUP)","year":"2020"},{"key":"10.1016\/j.aohep.2023.101108_bib0028","series-title":"SAS Institute, Cary, NC","first-page":"c1995","year":"1995"},{"issue":"3","key":"10.1016\/j.aohep.2023.101108_bib0029","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/14737167.2021.1927717","article-title":"Predictors of 30-day readmission and hospitalization costs of patients with hepatic encephalopathy in the US from 2010 to 2014","volume":"22","author":"Chen","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"12","key":"10.1016\/j.aohep.2023.101108_bib0030","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/apt.15749","article-title":"Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis","volume":"51","author":"Tapper","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.aohep.2023.101108_bib0031","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/liv.14054","article-title":"Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States","volume":"39","author":"Shaheen","year":"2019","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.aohep.2023.101108_bib0032","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s10620-018-4964-0","article-title":"Hospital cirrhosis volume and readmission in patients with cirrhosis in California","volume":"63","author":"Wei","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.aohep.2023.101108_bib0033","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/0733464819870983","article-title":"Individual and organizational factors associated with hospital readmission rates: evidence from a U.S. national sample","volume":"39","author":"Conner","year":"2020","journal-title":"J Appl Gerontol"},{"issue":"11","key":"10.1016\/j.aohep.2023.101108_bib0034","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/M17-1724","article-title":"Preventability of early versus late hospital readmissions in a national cohort of general medicine patients","volume":"168","author":"Graham","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.aohep.2023.101108_bib0035","first-page":"840","article-title":"Early palliative care referral in patients with end stage liver disease is associated with reduced resource utilisation","volume":"35","author":"Barnes","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2023.101108_bib0036","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jpainsymman.2019.07.011","article-title":"Outcomes of palliative care consultations for hospitalized patients with liver disease","volume":"58","author":"Ufere","year":"2019","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.aohep.2023.101108_bib0037","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.32378","article-title":"AASLD practice guidance: palliative care and symptom-based management in decompensated cirrhosis","volume":"76","author":"Rogal","year":"2022","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2023.101108_bib0038","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.mayocpiqo.2022.05.002","article-title":"Patients hospitalized for complications of cirrhosis may have benefited from medicaid expansion under the affordable care act","volume":"6","author":"Wang","year":"2022","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"1","key":"10.1016\/j.aohep.2023.101108_bib0039","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2022.07.028","article-title":"Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States","volume":"78","author":"Gao","year":"2023","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.aohep.2023.101108_bib0040","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/hep4.1802","article-title":"Independent predictors of mortality among patients with NAFLD hospitalized with COVID-19 infection","volume":"6","author":"Younossi","year":"2022","journal-title":"Hepatol Commun"},{"issue":"12","key":"10.1016\/j.aohep.2023.101108_bib0041","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/crj.13552","article-title":"The association of chronic liver disorders with exacerbation of symptoms and complications related to COVID-19: A systematic review and meta-analysis of cohort studies","volume":"16","author":"Afraie","year":"2022","journal-title":"Clin Respir J"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:46:57Z","timestamp":1761648417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268123002120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1665268123002120"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101108","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101108"}}